" So thankful to Cancer Rounds and Dr. Gaurav Dixit. Your care and support helped me heal and regain strength during my lymphoma treatment."
Venetoclax is a chemotherapy drug that works by reducing or stopping the progress of refractory acute myeloid leukemia cells in the body. It is responsible for the early treatment of adults with chronic lymphocytic (CLL) or small lymphocytic lymphoma (SLL).
Venetoclax is mainly a medication that blocks the action of a protein called BCL2 that helps the cancerous cell active. Both CLL and SLL do not involve any chemotherapy in its place that it targets the CD20 protein, which is present on the surface of tumor cells in refractory acute leukemia’s.
Confused about treatment options?
Get a free second opinion from our oncologists
Venetoclax is the common name for trade chemotherapy drug Venclexta that is an antineoplastic agent, BCL-2 inhibitor. It is ultimately an orally bioavailable minor BCL-2 molecule that is regulator protein, that regulates cell death by apoptosis, either inhibiting or inducing.
This drug works with binding to BCL-2, which is a protein that is present in malignant leukemic cells. Venetoclax breakdowns the lymphocytes that are accountable for chronic lymphocytic leukemia in the human body. Only appropriate for patients suffering from chronic lymphocytic cells (CLL).
Venetoclax is a simple therapy with deep and durable responses against AML patients. Patients receive Venetoclax from 1to 28 days up to one year in the absence of disease progression. If the patient accurately follows all these things as directed by the clinician, then you must see a satisfactory result.
Get expert guidance instantly
Tell us about your condition and we will help you find the right care.
February 17, 2024
January 4, 2024
June 16, 2023
Get expert guidance instantly
Share a few details and our medical team gets back to you within 4 hours with the next steps.
Tell us what you are facing and our medical team will guide you to the right doctors, hospitals and treatment.
Free Review, No Commitment
Free assessment with no pressure to proceed.
Trusted by 100,000+ Patients
Across 125+ countries worldwide
500+ Top Partner Hospitals
Globally accredited medical facilities
5000+ Expert Specialists
Senior doctors across major specialties.
Making quality healthcare accessible to patients worldwide
Everything you need to know about choosing the right hospital, doctor and treatment plan.